UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions
Full name: Paracetamol/Kodein Evolan 500 mg/30 mg Tablett
- Invented name part: Paracetamol/Kodein Evolan
- Strength part: 500 mg/30 mg
- Pharmaceutical dose form part: Tablett
Name usage: Swedish (Kingdom of Sweden)
Authorised dose form: Tablet
Legal status of supply: Medicinal product subject to special medical prescription
Domain: Human use
Resource status: Current
Product classification:
Marketing Authorisation 1 of 1
Authorisation number: 43144
Region: Kingdom of Sweden
Marketing authorisation holder: Evolan Pharma AB
Identifier:
Status: Valid (2011-02-18)
Package 1 of 4
PCID:
Description: Blister, 100 tabletter
Marketing status:
Pack size:
Package: 1 Box (Cardboard)
Containing:
Package: 10 Blister (Aluminium) (PolyVinyl Chloride)
Containing: 10 Tablet
Manufactured Item
Dose form: Tablet
Unit of presentation: Tablet
Ingredient
Role: Active
Substance: Paracetamol
Concentration strength: 500 milligram(s) / 1 unit(s)
Reference strength: Paracetamol 500 milligram(s) / 1 unit(s)
Ingredient
Role: Active
Substance: Codeine phosphate hemihydrate
Concentration strength: 30 milligram(s) / 1 unit(s)
Reference strength: Codeine anhydrous 22.1 milligram(s) / 1 unit(s)
Package 2 of 4
PCID:
Description: Blister, 20 tabletter
Marketing status:
Pack size:
Package: 1 Box (Cardboard)
Containing:
Package: 2 Blister (Aluminium) (PolyVinyl Chloride)
Containing: 10 Tablet
Manufactured Item
Dose form: Tablet
Unit of presentation: Tablet
Ingredient
Role: Active
Substance: Paracetamol
Concentration strength: 500 milligram(s) / 1 unit(s)
Reference strength: Paracetamol 500 milligram(s) / 1 unit(s)
Ingredient
Role: Active
Substance: Codeine phosphate hemihydrate
Concentration strength: 30 milligram(s) / 1 unit(s)
Reference strength: Codeine anhydrous 22.1 milligram(s) / 1 unit(s)
Package 3 of 4
PCID:
Description: Blister, 50 tabletter
Marketing status:
Pack size:
Package: 1 Box (Cardboard)
Containing:
Package: 5 Blister (Aluminium) (PolyVinyl Chloride)
Containing: 10 Tablet
Manufactured Item
Dose form: Tablet
Unit of presentation: Tablet
Ingredient
Role: Active
Substance: Paracetamol
Concentration strength: 500 milligram(s) / 1 unit(s)
Reference strength: Paracetamol 500 milligram(s) / 1 unit(s)
Ingredient
Role: Active
Substance: Codeine phosphate hemihydrate
Concentration strength: 30 milligram(s) / 1 unit(s)
Reference strength: Codeine anhydrous 22.1 milligram(s) / 1 unit(s)
Package 4 of 4
PCID:
Description: Blister, 56 tabletter
Marketing status:
Pack size:
Package: 1 Box (Cardboard)
Containing:
Package: 4 Blister (Aluminium) (PolyVinyl Chloride)
Containing: 14 Tablet
Manufactured Item
Dose form: Tablet
Unit of presentation: Tablet
Ingredient
Role: Active
Substance: Paracetamol
Concentration strength: 500 milligram(s) / 1 unit(s)
Reference strength: Paracetamol 500 milligram(s) / 1 unit(s)
Ingredient
Role: Active
Substance: Codeine phosphate hemihydrate
Concentration strength: 30 milligram(s) / 1 unit(s)
Reference strength: Codeine anhydrous 22.1 milligram(s) / 1 unit(s)
Administrable Product (1 of 1)
Dose form: Tablet
Unit of presentation:
Route of administration:
Ingredient
Role: Active
Substance: Paracetamol
Concentration strength: 500 milligram(s) / 1 unit(s)
Reference strength: Paracetamol 500 milligram(s) / 1 unit(s)
Ingredient
Role: Active
Substance: Codeine phosphate hemihydrate
Concentration strength: 30 milligram(s) / 1 unit(s)
Reference strength: Codeine anhydrous 22.1 milligram(s) / 1 unit(s)